Skip to content

A randomized controlled clinical trial of the Connective Tissue Wall technique for the treatment of RT2/RT3 gingival recession with infra-bony defect

A prospective, Randomized Controlled Trial of the Efficacy of Connective Tissue Wall Technique in the Treatment of RT2/RT3 Gingival Recession with Concurrent periodontal intrabony defects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094427
Enrollment
Unknown
Registered
2024-12-23
Start date
2024-12-23
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival recession with infra-bony defects

Interventions

Test Group:Connective Tissue Wall Technique: Make papilla preservation incisions and a semi-thickness to full-thickness flap. Then fully debride granulation tissue and expose the infra-bony defect tho
Control Group:Combined GTR and bone subsititutes grafting: After thorough debridement and complete exposure of the infra-bony defect, fill the DBBM (Geistlich Bio-oss) subsititutes. Suture the outer f

Sponsors

Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Age 18-70 years old, female or male. 2) Patients already accepted initial periodontal treatment. 3) Patients with at least one tooth classified by the Cairo classification as RT2/RT3 gingival recession without tooth mobility and CBCT showing a infra-bony defect of at least 3mm without bleeding on probing and a probing depth of no more than 3mm at adjecent teeth. 4) No smoking or less than 10 cigarettes per day; 5) No medical contraindications for oral surgery or regenerative surgery.

Exclusion criteria

Exclusion criteria: 1) Patients with a history of open debridement surgery at the infra-bony defect site within the past one year; 2) Patients without RT2/RT3 gingival recession or infra-bony defect site. 3) Patients with advanced perodontitis. 4) Patients with uncontrolled dabetes, ie, fasting plasma glucose >=8.88mmol/L after medication control; 5) Patients with uncontrolled severe hypertension, ie, >160/90 mmHg; 6) Patients with cardiovascular disease, ie, class II or higher cardiac function disorder; 7) Patients with impaired liver or renal function, ie, serum creatinine > 1.5 mg/dl or with active hepatitis or decompensated cirrhosis; 8) Patients with a history of full-dose radiation therapy or local radiation therapy in the head and neck area; 9) Patients with impaired immune function; 10) Patients who smoke tobacco or tobacco equivalents or chew tobacco, >= 10 cigarettes daily; 11) Patients with poor compliance.

Design outcomes

Primary

MeasureTime frame
Gingival Recession,REC;Filled infra-bony Rate, FBR;

Secondary

MeasureTime frame
Pocket Probing Depth, PPD;Keratinized Gingival Width, KGW;Bleeding Score Index, BI;Plaque Index, PI;Gingival Area Gain, GAG;Gingival Mean Thickness, GMT;Tissue Thick Change, TTC;

Countries

China

Contacts

Public ContactNi Jing

Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine

natalie1229_9@126.com+86 139 1842 4828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026